Crossmark

Thromboprophylaxis in critical care

Published Online: 2022-08-29

Published Print: 2023-01

Authors

Helms, Julie https://orcid.org/0000-0003-0895-6800
Middeldorp, Saskia

Spyropoulos, Alex C.
License Information

Text and Data Mining valid from 2022-08-29

Version of Record valid from 2022-08-29
More Information

Article History

Received: 13 June 2022

Accepted: 29 July 2022

First Online: 29 August 2022

Declarations

:

: JH has received honoraria for lectures from Diagnostica Stago, Pfizer PFE France and Sanofi Aventis France. SM has received personal fees from Daiichi Sankyo, Bayer, Pfizer, Boehringer Ingelheim, Portola/Alexion, AbbVie, BMS-Pfizer, Sanofi, and Viatris, all paid to her institution, and grants from Daiichi Sankyo, Bayer, Pfizer, and Boehringer Ingelheim. AS received consultant fees from Janssen, Bayer, Bristol Myer Squibb, Sanofi, Alexion, ATLAS Group and research Funds from Janssen.

Document is current